Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

5,372 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Ventricular tachyarrhythmia and sudden cardiac death with domperidone use in Parkinson's disease.
Renoux C, Dell'Aniello S, Khairy P, Marras C, Bugden S, Turin TC, Blais L, Tamim H, Evans C, Steele R, Dormuth C, Ernst P; Canadian Network for Observational Drug Effect Studies (CNODES) investigators. Renoux C, et al. Among authors: evans c. Br J Clin Pharmacol. 2016 Aug;82(2):461-72. doi: 10.1111/bcp.12964. Epub 2016 May 19. Br J Clin Pharmacol. 2016. PMID: 27062307 Free PMC article.
Mental comorbidity and multiple sclerosis: validating administrative data to support population-based surveillance.
Marrie RA, Fisk JD, Yu BN, Leung S, Elliott L, Caetano P, Warren S, Evans C, Wolfson C, Svenson LW, Tremlett H, Blanchard JF, Patten SB; CIHR Team in the Epidemiology and Impact of Comorbidity on Multiple Sclerosis. Marrie RA, et al. Among authors: evans c. BMC Neurol. 2013 Feb 6;13:16. doi: 10.1186/1471-2377-13-16. BMC Neurol. 2013. PMID: 23388102 Free PMC article.
Determinants of non-adherence to disease-modifying therapies in multiple sclerosis: A cross-Canada prospective study.
McKay KA, Tremlett H, Patten SB, Fisk JD, Evans C, Fiest K, Campbell T, Marrie RA; CIHR Team in the Epidemiology and Impact of Comorbidity on Multiple Sclerosis (ECoMS). McKay KA, et al. Among authors: evans c. Mult Scler. 2017 Apr;23(4):588-596. doi: 10.1177/1352458516657440. Epub 2016 Jul 11. Mult Scler. 2017. PMID: 27357507 Free PMC article.
Evaluating the safety of β-interferons in MS: A series of nested case-control studies.
de Jong HJI, Kingwell E, Shirani A, Cohen Tervaert JW, Hupperts R, Zhao Y, Zhu F, Evans C, van der Kop ML, Traboulsee A, Gustafson P, Petkau J, Marrie RA, Tremlett H; British Columbia Multiple Sclerosis Clinic Neurologists. de Jong HJI, et al. Among authors: evans c. Neurology. 2017 Jun 13;88(24):2310-2320. doi: 10.1212/WNL.0000000000004037. Epub 2017 May 12. Neurology. 2017. PMID: 28500224 Free PMC article.
Comorbidity increases the risk of relapse in multiple sclerosis: A prospective study.
Kowalec K, McKay KA, Patten SB, Fisk JD, Evans C, Tremlett H, Marrie RA; CIHR Team in Epidemiology and Impact of Comorbidity on Multiple Sclerosis (ECoMS). Kowalec K, et al. Among authors: evans c. Neurology. 2017 Dec 12;89(24):2455-2461. doi: 10.1212/WNL.0000000000004716. Epub 2017 Nov 8. Neurology. 2017. PMID: 29117961 Free PMC article.
5,372 results